Gábor Horváth Selected Research

Gábor Horváth Research Topics

Disease

13	Fibrosis (Cirrhosis) 01/2020 - 03/2012
12	Infections 01/2022 - 02/2006
10	Chronic Hepatitis C 12/2015 - 01/2004
8	Inflammation (Inflammations) 01/2018 - 08/2007
7	Hepatitis C 01/2022 - 06/2004
6	Hepatitis D 01/2018 - 03/2012
6	Chronic Hepatitis B 01/2017 - 03/2012
4	Crohn Disease (Crohn's Disease) 01/2020 - 09/2009
4	Ulcerative Colitis 01/2020 - 03/2013
4	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 08/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 06/2007
3	Hepatitis B 07/2013 - 01/2010
3	Neoplasms (Cancer) 09/2010 - 11/2002
3	Hepatitis 02/2006 - 05/2004
2	Liver Diseases (Liver Disease) 06/2018 - 01/2018
2	Anemia 08/2016 - 02/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2016 - 08/2007
2	Agranulocytosis (Granulocytopenia) 08/2016 - 02/2006
2	Fistula 11/2011 - 09/2009
2	Breast Neoplasms (Breast Cancer) 04/2005 - 11/2002
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019
1	Granuloma 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Pneumonia (Pneumonitis) 06/2018
1	Myocardial Infarction 06/2018
1	Gingivitis 08/2016
1	Dermatitis 08/2016
1	Fatigue 08/2016
1	Hypertension (High Blood Pressure) 06/2015
1	Lipodystrophy 06/2015
1	Chordoma 12/2013
1	Non-alcoholic Fatty Liver Disease 07/2013
1	Viremia 07/2013
1	Disease Progression 05/2011
1	Carcinogenesis 02/2011
1	Neoplasm Metastasis (Metastasis) 09/2010
1	Adenocarcinoma 09/2010
1	Carcinoma (Carcinomatosis) 09/2010
1	Liver Neoplasms (Liver Cancer) 09/2010
1	Colorectal Neoplasms (Colorectal Cancer) 09/2010
1	Cholangiocarcinoma 09/2010
1	Pancreatic Ductal Carcinoma 09/2010
1	Hypoxia (Hypoxemia) 01/2010
1	Retinal Degeneration 03/2009
1	Calculi (Calculus) 10/2008
1	Aneuploidy (Aneuploid) 10/2008

Drug/Important Bio-Agent (IBA)

14	InterferonsIBA 01/2018 - 02/2006
13	Antiviral Agents (Antivirals)IBA 01/2022 - 05/2004
6	Tenofovir (Viread)FDA Link 01/2018 - 07/2013
5	entecavir FDA Link 01/2018 - 03/2012
4	Ribavirin (Virazole)FDA LinkGeneric 08/2016 - 02/2006
4	Protease Inhibitors (Protease Inhibitor)IBA 05/2015 - 03/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2006
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 06/2018 - 03/2012
3	Transaminases (Aminotransferases)IBA 06/2018 - 01/2016
3	Adalimumab (Humira)FDA Link 05/2016 - 09/2011
2	telaprevirIBA 06/2018 - 03/2012
2	Infliximab (Remicade)FDA Link 05/2016 - 09/2009
2	SteroidsIBA 03/2013 - 09/2009
2	Monoclonal AntibodiesIBA 09/2011 - 11/2002
2	LipidsIBA 06/2007 - 11/2002
2	Interferon-alpha (Interferon Alfa)IBA 02/2006 - 06/2004
2	Trastuzumab (Herceptin)FDA Link 04/2005 - 11/2002
1	vedolizumabIBA 01/2020
1	glecaprevir and pibrentasvirIBA 01/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 07/2015
1	MicroRNAs (MicroRNA)IBA 07/2015
1	Lopinavir FDA Link 06/2015
1	SimeprevirIBA 05/2015
1	daclatasvirIBA 05/2015
1	asunaprevirIBA 05/2015
1	paritaprevirIBA 05/2015
1	ombitasvirIBA 05/2015
1	ledipasvirIBA 05/2015
1	dasabuvirIBA 05/2015
1	SofosbuvirIBA 05/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2013
1	Immunologic Factors (Immunomodulators)IBA 07/2013
1	Rituximab (Mabthera)FDA Link 07/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011
1	Phenobarbital (Luminal)FDA Link 09/2011
1	Arachidonic Acid (Vitamin F)IBA 02/2011
1	AgrinIBA 09/2010
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 09/2010
1	CadmiumIBA 01/2010
1	Sodium Glutamate (Accent)IBA 03/2009
1	Retinaldehyde (Retinal)IBA 03/2009
1	DNA (Deoxyribonucleic Acid)IBA 10/2008

Therapy/Procedure

31	Therapeutics 06/2018 - 01/2004
7	Contraindications 01/2018 - 05/2011
2	Drug Therapy (Chemotherapy) 07/2013 - 11/2012
1	Aftercare (After-Treatment) 03/2015
1	Radiotherapy 12/2013
1	Reducing Diet 07/2013
1	Organ Transplantation 06/2012
1	Esophagectomy 11/2011
1	Biological Therapy 09/2011
1	Oral Hygiene (Dental Hygiene) 10/2008
1	Root Planing 10/2008